Radhika Gupta is a Principal at CTI Life Sciences Fund who focuses on complex, high-barrier healthcare markets like neurology and reimbursement-restricted care, bringing a rare combination of scientific, commercial, and financial expertise that CTI highlights as her unique ability to integrate diligence across these dimensions. Before joining CTI, she co-founded and successfully exited NTX Services, a Montreal-based advisory that provided diligence, financial modeling, and go-to-market strategy to over 150 healthtech ventures globally, and also co-founded Myelin Capital, a specialized firm focused on capital raises and M&A for neurotech startups across North America, Europe, and Asia.